Cargando…

Matrix metalloproteinases in coronary artery disease and myocardial infarction

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide. Most cardiovascular deaths are caused by ischaemic heart diseases such as myocardial infarction (MI). Hereby atherosclerosis in the coronary arteries often precedes disease manifestation. Since tissue remodelling plays an im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bräuninger, Hanna, Krüger, Saskia, Bacmeister, Lucas, Nyström, Alexander, Eyerich, Kilian, Westermann, Dirk, Lindner, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169894/ https://www.ncbi.nlm.nih.gov/pubmed/37160529 http://dx.doi.org/10.1007/s00395-023-00987-2

Ejemplares similares

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Macrophage Migration Inhibitory Factor (MIF) Expression Increases during Myocardial Infarction and Supports Pro-Inflammatory Signaling in Cardiac Fibroblasts
por: Voss, Svenja, et al.
Publicado: (2019)

Matrix metalloproteinases and their gene polymorphism in young ST-segment elevation myocardial infarction
por: Basia, Deepak, et al.
Publicado: (2022)

Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD
por: Polonskaya, Yana V., et al.
Publicado: (2021)

Usefulness of plasma matrix metalloproteinase-9 levels in prediction of in-hospital mortality in patients who received emergent percutaneous coronary artery intervention following myocardial infarction
por: Zhu, Jia-Jun, et al.
Publicado: (2017)

Genetic Polymorphism of Matrix Metalloproteinase-9 and Susceptibility to Myocardial Infarction: A Meta-Analysis
por: Feng, Beili, et al.
Publicado: (2022)

Myocardial Injury Promotes Matrix Metalloproteinase-9 Activity in the Renal Cortex in Preclinical Models of Acute Myocardial Infarction
por: Qiao, Xiaoying, et al.
Publicado: (2021)

Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women
por: Jefferis, Barbara J., et al.
Publicado: (2010)

Planned versus unplanned rotational atherectomy for plaque modification in severely calcified coronary lesions
por: Bacmeister, Lucas, et al.
Publicado: (2023)

Correlation Between Matrix Metalloproteinases With Coronary Artery Lesion Caused by Kawasaki Disease
por: Tian, Fang, et al.
Publicado: (2022)

Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)

Expression of matrix metalloproteinases-12 in ST-segment elevation myocardial infarction: A case–control study
por: Wang, Jing, et al.
Publicado: (2017)

Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease
por: Shimizu, Chisato, et al.
Publicado: (2010)

Matrix Metalloproteinase-2 Polymorphisms and Incident Coronary Artery Disease: A Meta-Analysis
por: Shi, Yujie, et al.
Publicado: (2015)

Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease
por: Samah, Nazirah, et al.
Publicado: (2023)

Association of Matrix Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis
por: Juan, Zhang, et al.
Publicado: (2015)

Coronary artery ectasia in a patient with myocardial infarction
por: ML, Jesuraj, et al.
Publicado: (2011)

Common coronary artery occlusions in patients with myocardial infarction
por: Ahmed, Itedal Abdelraheem Mohamed, et al.
Publicado: (2022)

Myocardial infarction with non-obstructive coronary arteries (MINOCA)
por: Yildiz, Mehmet, et al.
Publicado: (2022)

The Significance of Recognizing Myocardial Bridge in the Coronary Spasm Diagnosis in Myocardial Infarction with Nonobstructive Coronary Arteries
por: Teragawa, Hiroki, et al.
Publicado: (2019)

Matrix Metalloproteinase 13 Genotype in rs640198 Polymorphism Is Associated with Severe Coronary Artery Disease
por: Vašků, Anna, et al.
Publicado: (2012)

Circulating Matrix Metalloproteinase-28 Levels Are Related to GRACE Scores and Short-Term Outcomes in Patients with Acute Myocardial Infarction
por: Zhou, Ke, et al.
Publicado: (2020)

The Role of Echocardiography in Coronary Artery Disease and Acute Myocardial Infarction
por: Esmaeilzadeh, Maryam, et al.
Publicado: (2013)

Epicardial Coronary Arteries in Khat Chewers Presenting with Myocardial Infarction
por: Al-Motarreb, Ahmed, et al.
Publicado: (2013)

Recurrent Multivessel Coronary Artery Spasm Presented as Myocardial Infarction
por: Zhang, Hao, et al.
Publicado: (2016)

Myocardial infarction with non-obstructive coronary arteries: what is the prognosis?
por: Niccoli, Giampaolo, et al.
Publicado: (2020)

Myocardial Infarction with Nonobstructive Coronary Arteries: A Diagnostic Challenge
por: Asamoah, Kofi Tekyi
Publicado: (2021)

Postmortem coronary artery calcium score in cases of myocardial infarction
por: Michaud, Katarzyna, et al.
Publicado: (2021)

Myocardial Infarction and Persistent Angina With No Obstructive Coronary Artery Disease
por: Malas, Waddah, et al.
Publicado: (2020)

Coronary Artery-Ventricular Pseudoaneurysm Fistula After Myocardial Infarction
por: Kobayashi, Ken, et al.
Publicado: (2022)

Interferon-Gamma Increases the Ratio of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 in Peripheral Monocytes from Patients with Coronary Artery Disease
por: Springall, Rashidi, et al.
Publicado: (2013)

Mortality in ST-Segment Elevation Myocardial Infarction With Nonobstructive Coronary Arteries and Mimickers
por: Quesada, Odayme, et al.
Publicado: (2023)

Correlation between genetic polymorphism of matrix metalloproteinase-9 in patients with coronary artery disease and cardiac remodeling
por: Yu, Qibin, et al.
Publicado: (2015)

The Influence of Autologous Bone Marrow Stem Cell Transplantation on Matrix Metalloproteinases in Patients Treated for Acute ST-Elevation Myocardial Infarction
por: Furenes, Eline Bredal, et al.
Publicado: (2014)

Predictive Utility of the Changes in Matrix Metalloproteinase‐2 in the Early Phase for Left Ventricular Reverse Remodeling After an Acute Myocardial Infarction
por: Morishita, Tetsuji, et al.
Publicado: (2015)

Matrix Metalloproteinase Mediated Type I Collagen Degradation is an Independent Predictor of Increased Risk of Acute Myocardial Infarction in Postmenopausal Women
por: Bertelsen, Ditte Marie, et al.
Publicado: (2018)

Higher levels of TWEAK and matrix metalloproteinase-3 during the acute phase of myocardial infarction are associated with adverse left ventricular remodeling
por: Eyyupkoca, Ferhat, et al.
Publicado: (2021)

Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases–INVITATION Trial–
por: Shirakawa, Takuhiro, et al.
Publicado: (2022)

Myocardial ischemia and previous infarction contribute to left ventricular dyssynchrony in patients with coronary artery disease
por: Hämäläinen, Hanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0nbu9mj336avcs8midq4rrf1ei